These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8982660)

  • 1. Neuropharmacological profile of EMD 57445, a sigma receptor ligand with potential antipsychotic activity.
    Maj J; Rogóz Z; Skuza G; Mazela H
    Eur J Pharmacol; 1996 Nov; 315(3):235-43. PubMed ID: 8982660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychopharmacological profile of remoxipride in comparison with clozapine.
    Skuza G; Rogóz Z; Wieczorek A
    Pol J Pharmacol; 1997; 49(1):5-15. PubMed ID: 9431546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of local intracerebral administration of EMD 57445, a selective sigma receptor ligand, on the locomotor activity of the rat.
    Skuza G; Kolasiewicz W; Dziedzicka-Wasylewska M; Margas W
    Pol J Pharmacol; 1998; 50(6):399-406. PubMed ID: 10385922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some behavioral effects of 1,3-di-o-tolylguanidine, opipramol and sertraline, the sigma site ligands.
    Maj J; Rogóz Z; Skuza G
    Pol J Pharmacol; 1996; 48(4):379-95. PubMed ID: 9112678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACP-103, a 5-hydroxytryptamine 2A receptor inverse agonist, improves the antipsychotic efficacy and side-effect profile of haloperidol and risperidone in experimental models.
    Gardell LR; Vanover KE; Pounds L; Johnson RW; Barido R; Anderson GT; Veinbergs I; Dyssegaard A; Brunmark P; Tabatabaei A; Davis RE; Brann MR; Hacksell U; Bonhaus DW
    J Pharmacol Exp Ther; 2007 Aug; 322(2):862-70. PubMed ID: 17519387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roxindole, a potential antidepressant. I. Effect on the dopamine system.
    Maj J; Kolodziejczyk K; Rogóz Z; Skuza G
    J Neural Transm (Vienna); 1996; 103(5):627-41. PubMed ID: 8811507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of EMD 57445, the selective sigma receptor ligand, on the turnover and release of dopamine.
    Skuza G; Gołembiowska K; Wedzony K
    Pol J Pharmacol; 1998; 50(1):61-4. PubMed ID: 9662740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine, and 11 other antipsychotic agents.
    Millan MJ; Brocco M; Rivet JM; Audinot V; Newman-Tancredi A; Maiofiss L; Queriaux S; Despaux N; Peglion JL; Dekeyne A
    J Pharmacol Exp Ther; 2000 Jan; 292(1):54-66. PubMed ID: 10604931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of sigma ligands on the cocaine-induced convulsions in mice.
    Skuza G
    Pol J Pharmacol; 1999; 51(6):477-83. PubMed ID: 10817525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facilitation of dopamine D1 receptor- but not dopamine D1/D2 receptor-dependent locomotion by glutamate antagonists in the reserpine-treated mouse.
    Starr MS; Starr BS
    Eur J Pharmacol; 1993 Dec; 250(2):239-46. PubMed ID: 7906652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests.
    Bristow LJ; Collinson N; Cook GP; Curtis N; Freedman SB; Kulagowski JJ; Leeson PD; Patel S; Ragan CI; Ridgill M; Saywell KL; Tricklebank MD
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1256-63. PubMed ID: 9400001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 1,3-di-o-tolylguanidine (DTG), rimcazole and EMD 57445, the sigma receptor ligands, in the forced swimming test.
    Skuza G; Rogóz Z
    Pol J Pharmacol; 1997; 49(5):329-35. PubMed ID: 9566032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EMD 57445, the selective sigma receptor ligand, has no effect on the 5-hydroxytryptamine system.
    Skuza G; Rogóz Z; Gołembiowska K
    Pol J Pharmacol; 1997; 49(6):489-93. PubMed ID: 9566054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sigma ligand S14905 and locomotor activity in mice.
    Hascoet M; Bourin M; Payeur R; Lombet A; Peglion JL
    Eur Neuropsychopharmacol; 1995 Dec; 5(4):481-9. PubMed ID: 8998401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of JNJ-37822681, a specific and fast-dissociating D2 antagonist for the treatment of schizophrenia.
    Langlois X; Megens A; Lavreysen H; Atack J; Cik M; te Riele P; Peeters L; Wouters R; Vermeire J; Hendrickx H; Macdonald G; De Bruyn M
    J Pharmacol Exp Ther; 2012 Jul; 342(1):91-105. PubMed ID: 22490380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Atypical antipsychotic profiles of sigma receptor ligands].
    Okuyama S
    Nihon Yakurigaku Zasshi; 1999 Jul; 114(1):13-23. PubMed ID: 10562961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occupancy of striatal D(2)-like dopamine receptors after treatment with the sigma ligand EMD 57445, a putative atypical antipsychotic.
    Gründer G; Müller MJ; Andreas J; Heydari N; Wetzel H; Schlösser R; Schlegel S; Nickel O; Eissner D; Benkert O
    Psychopharmacology (Berl); 1999 Sep; 146(1):81-6. PubMed ID: 10485968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone.
    Martin P; Waters N; Schmidt CJ; Carlsson A; Carlsson ML
    J Neural Transm (Vienna); 1998; 105(4-5):365-96. PubMed ID: 9720968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity.
    Marquis KL; Sabb AL; Logue SF; Brennan JA; Piesla MJ; Comery TA; Grauer SM; Ashby CR; Nguyen HQ; Dawson LA; Barrett JE; Stack G; Meltzer HY; Harrison BL; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 2007 Jan; 320(1):486-96. PubMed ID: 17038512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.